Skip to Content

Press Releases

Press Releases

Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer
Sep 23, 2022
Tiziana Life Sciences Announces Continued Clinical Improvements in the Second Patient with Secondary Progressive Multiple Sclerosis (SPMS) After Six Months of Dosing with Intranasal Foralumab
Sep 20, 2022
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
Sep 16, 2022
Tiziana Life Sciences Announces Grant received by the Brigham and Women’s Hospital to Explore the Use of Intranasal anti-CD3 mAb in Amyotrophic Lateral Sclerosis
Sep 15, 2022
Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer
Sep 09, 2022
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
Aug 25, 2022
Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman
Aug 17, 2022
Tiziana Life Sciences Announces Presentation at Alzheimer’s Association International Conference® 2022 (AAIC®) Evaluating Intranasal anti-CD3 for the Potential Treatment of Alzheimer’s Disease
Aug 01, 2022
Tiziana Life Sciences Appoints Matthew W. Davis, MD, RPh as Chief Medical Officer and Acting Chief Scientific Officer
Jul 18, 2022
Tiziana Life Sciences Announces Resignation of CEO
Jul 15, 2022
Displaying 1 - 10 of 406